153 related articles for article (PubMed ID: 2825484)
1. Inhibition of LTB4 binding to human neutrophils by nordihydroguaiaretic acid.
Maloff BL; Fefer D; Cooke GM; Ackerman NR
Agents Actions; 1987 Aug; 21(3-4):358-60. PubMed ID: 2825484
[TBL] [Abstract][Full Text] [Related]
2. Lipoxins A4 and B4 inhibit leukotriene B4 generation from human neutrophil leukocyte suspensions.
Conti P; Reale M; Barbacane RC; Bongrazio M; Panara MR
Immunol Lett; 1990 Jul; 24(4):237-42. PubMed ID: 2167876
[TBL] [Abstract][Full Text] [Related]
3. Dapsone inhibits LTB4 binding and bioresponse at the cellular and physiologic levels.
Maloff BL; Fox D; Bruin E; Di Meo TM
Eur J Pharmacol; 1988 Dec; 158(1-2):85-9. PubMed ID: 2851461
[TBL] [Abstract][Full Text] [Related]
4. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils.
Tsai BS; Keith RH; Villani-Price D; Haack RA; Djuric SW
J Pharmacol Exp Ther; 1994 Mar; 268(3):1493-8. PubMed ID: 8138959
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
Jackson WT; Froelich LL; Boyd RJ; Schrementi JP; Saussy DL; Schultz RM; Sawyer JS; Sofia MJ; Herron DK; Goodson T; Snyder DW; Pechous PA; Spaethe SM; Roman CR; Fleisch JH
J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783
[TBL] [Abstract][Full Text] [Related]
6. Leukotriene B4 induces formation of inositol phosphates in rat peritoneal polymorphonuclear leukocytes.
Mong S; Chi-Rosso G; Miller J; Hoffman K; Razgaitis KA; Bender P; Crooke ST
Mol Pharmacol; 1986 Sep; 30(3):235-42. PubMed ID: 3018480
[TBL] [Abstract][Full Text] [Related]
7. ONO-4057, a novel, orally active leukotriene B4 antagonist: effects on LTB4-induced neutrophil functions.
Kishikawa K; Tateishi N; Maruyama T; Seo R; Toda M; Miyamoto T
Prostaglandins; 1992 Oct; 44(4):261-75. PubMed ID: 1332129
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.
Goldman DW; Enkel H; Gifford LA; Chenoweth DE; Rosenbaum JT
J Immunol; 1986 Sep; 137(6):1971-6. PubMed ID: 3018083
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of 20-trifluoromethyl leukotriene B4 on human neutrophil functions.
Tsai BS; Keith RH; Villani-Price D; Haack RA; Bauer RF; Leonard R; Abe Y; Nicolaou KC
Prostaglandins; 1989 Feb; 37(2):287-302. PubMed ID: 2543037
[TBL] [Abstract][Full Text] [Related]
10. Specific binding of leukotriene B4 to a receptor on human polymorphonuclear leukocytes.
Kreisle RA; Parker CW
J Exp Med; 1983 Feb; 157(2):628-41. PubMed ID: 6296265
[TBL] [Abstract][Full Text] [Related]
11. Oxidation of leukotrienes at the omega end: demonstration of a receptor for the 20-hydroxy derivative of leukotriene B4 on human neutrophils and implications for the analysis of leukotriene receptors.
Clancy RM; Dahinden CA; Hugli TE
Proc Natl Acad Sci U S A; 1984 Sep; 81(18):5729-33. PubMed ID: 6091105
[TBL] [Abstract][Full Text] [Related]
12. Ca2+ ionophore A23187-stimulated secretion of azurophil granules in human polymorphonuclear leukocytes is largely mediated by endogenously formed leukotriene B4.
Hatzelmann A; Fruchtmann R; Mohrs KH; Raddatz S; Müller-Peddinghaus R
Biochem Pharmacol; 1994 Jul; 48(1):31-9. PubMed ID: 8043028
[TBL] [Abstract][Full Text] [Related]
13. Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage.
Martin TR; Raugi G; Merritt TL; Henderson WR
J Clin Invest; 1987 Oct; 80(4):1114-24. PubMed ID: 2821074
[TBL] [Abstract][Full Text] [Related]
14. Selective modulation by guanine nucleotides of the high affinity subset of plasma membrane receptors for leukotriene B4 on human polymorphonuclear leukocytes.
Sherman JW; Goetzl EJ; Koo CH
J Immunol; 1988 Jun; 140(11):3900-4. PubMed ID: 2836504
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and pharmacological evaluation of potent xanthone dicarboxylic acid leukotriene B4 receptor antagonists.
Jackson WT; Boyd RJ; Froelich LL; Gapinski DM; Mallett BE; Sawyer JS
J Med Chem; 1993 Jun; 36(12):1726-34. PubMed ID: 8389876
[TBL] [Abstract][Full Text] [Related]
16. Transduction by leukotriene B4 receptors of increases in cytosolic calcium in human polymorphonuclear leukocytes.
Goldman DW; Gifford LA; Olson DM; Goetzl EJ
J Immunol; 1985 Jul; 135(1):525-30. PubMed ID: 2987349
[TBL] [Abstract][Full Text] [Related]
17. Evidence that activation of a common G-protein by receptors for leukotriene B4 and N-formylmethionyl-leucyl-phenylalanine in HL-60 cells occurs by different mechanisms.
McLeish KR; Gierschik P; Schepers T; Sidiropoulos D; Jakobs KH
Biochem J; 1989 Jun; 260(2):427-34. PubMed ID: 2548477
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the heterogeneous membrane potential response of neutrophils to N-formyl-methionyl-leucyl-phenylalanine (FMLP) by leukotriene B4: evidence for cell recruitment.
Fletcher MP
J Immunol; 1986 Jun; 136(11):4213-9. PubMed ID: 3009618
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the pharmacological profile of the potent LTB4 antagonist CP-105,696 on murine LTB4 receptors in vitro.
Showell HJ; Breslow R; Conklyn MJ; Hingorani GP; Koch K
Br J Pharmacol; 1996 Mar; 117(6):1127-32. PubMed ID: 8882606
[TBL] [Abstract][Full Text] [Related]
20. Products of the lipoxygenase pathway in human natural killer cell cytotoxicity.
Rossi P; Lindgren JA; Kullman C; Jondal M
Cell Immunol; 1985 Jun; 93(1):1-8. PubMed ID: 2986854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
